About Heer Pharma Private Limited
Data last updated:
Heer Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 22 June 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1993PTC072516. Its GSTIN is 27AAACH8217P1Z5 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.1 Lakh. It was formerly known as Heer Trade-Chem Private Limited. It is led by directors including Prashant Kirit Shah (Managing Director) and Beejal Prashant Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹52 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Cr (net margin 2.3%) and EBITDA of ₹1.63 Cr (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 16% over five years.
The company is associated with 1 brand: Heer Pharma. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2015. Its 10 peer companies in the Pharma industry (Animal Pharma) are compared by revenue, 5 larger and 5 smaller; the largest is Unichemie International Private Limited with revenue of ₹58.91 Cr. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 3 overdue payments to 3 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heerpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No 317 Unique Industrial Estate 3rd Floor Off V S Marg Twin Tower Lane Prabhadev, I, Mumbai, Maharashtra, India – 400025
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Heer Pharma Private Limited
Heer Pharma operates one associated brand: Heer Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports APIs, veterinary drugs, and excipients for global markets. | heerpharma.com |
Business Activity of Heer Pharma Private Limited
The main business activity of Heer Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Heer Pharma Private Limited FY 2025 filings available
Heer Pharma Private Limited reported revenue of ₹52 Cr (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Heer Pharma Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Heer Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹52 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.63 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.17 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Heer Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Heer Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Heer Pharma Private Limited
Heer Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrudula Kirit Shah | Director | 22 Jun 1993 | 33 Years 4 Months | Current |
| Prashant Kirit Shah Also directs: Neha Pharma Pvt Ltd | Managing Director | 04 Apr 1995 | 31 Years 6 Months | Current |
| Beejal Prashant Shah | Whole-Time Director | 03 Apr 2006 | 20 Years 6 Months | Current |
Peer Comparison of Heer Pharma Private Limited
Heer Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unichemie International Private Limited | ₹58.91 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Scitech Specialities Private Limited | ₹56.53 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Hindustan Therapeutics Private Limited | ₹54.08 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Wellcon Animal Health Private Limited | ₹53.42 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Agra, Uttar Pradesh, India |
| Intracin Pharmaceuticals Private Limited | ₹52.07 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Nadiad, Gujarat, India |
| Heer Pharma Private Limited this company | ₹52 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Dosch Pharmaceuticals Pvt Ltd | ₹49.93 Cr (FY 2019) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Simfa Labs Private Limited | ₹49.61 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Indore, Madhya Pradesh, India |
| Nutrivet Farm Care Private Limited | ₹49.27 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Patna, Bihar, India |
| PP & B Mart Private Limited | ₹44.58 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Kolkata, West Bengal, India |
| Sai Deep Exports Private Limited | ₹43.82 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Heer Pharma by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Heer Pharma Private Limited
Heer Pharma Private Limited is audited by Rasik R. Thakkar for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rasik R. Thakkar | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Heer Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Heer Pharma Private Limited
Heer Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Heer Pharma Private Limited
Heer Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Heer Pharma Private Limited
Heer Pharma Private Limited has 4 court cases on record: 3 filed by Heer Pharma, 1 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed by the company against Chandrakant Gupta Owner of Ashutosh Chemicals | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrent Cases SW) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed by the company against M-S Dinesh Pharmaceuticals P Ltd. | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Heer Pharma Private Limited
Heer Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 3 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Siflon Drugs | •••• | •••• | •••• |
| Apex Healthcare Limited | •••• | •••• | •••• |
| Ascent Pharma | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Heer Pharma Private Limited
Employment history and EPFO contributions of people linked to Heer Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Heer Pharma Private Limited
Heer Pharma Private Limited has 3 board changes on record since 1993: 3 appointments. The latest: Beejal Prashant Shah was appointed as Whole-Time Director on 03 Apr 2006.
Credit Ratings, Litigation & Regulatory Alerts for Heer Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Heer Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Heer Pharma Private Limited
Heer Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACH8217P1Z5 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Heer Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Heer Pharma Private Limited
Heer Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 22 June 1993 (33+ years old) and is registered under CIN U51900MH1993PTC072516.
Heer Pharma reported revenue of ₹52 Cr for FY 2024 (down 4% YoY).
Heer Pharma has 3 current directors:
- Prashant Kirit Shah - Managing Director
- Beejal Prashant Shah - Whole-Time Director
- Mrudula Kirit Shah - Director
Heer Pharma reported a net profit of ₹1.17 Cr (net margin 2.3%) and EBITDA of ₹1.63 Cr (EBITDA margin 3.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Heer Pharma is -2% over three years and 16% over five years. In the latest year (FY 2024) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Heer Pharma is 27AAACH8217P1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Heer Pharma is U51900MH1993PTC072516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heer Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 2 are pending.
Heer Pharma was incorporated on 22 June 1993, making it 33+ years old. It is registered with the Registrar of Companies, Mumbai.
Heer Pharma has 1 deal on record (1 secondary share transfer); the latest was in March 2015.
The peers of Heer Pharma by revenue are Unichemie International Private Limited, Scitech Specialities Private Limited, Hindustan Therapeutics Private Limited, Wellcon Animal Health Private Limited, Intracin Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Animal Pharma).
Beejal Prashant Shah was appointed as Whole-Time Director on 03 Apr 2006. Prashant Kirit Shah was appointed as Managing Director on 04 Apr 1995. Mrudula Kirit Shah was appointed as Director on 22 Jun 1993.